Return On Equity of Monte Rosa Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Monte Rosa Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Monte Rosa Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 8.3%.
  • Monte Rosa Therapeutics, Inc. annual Return On Equity for 2024 was -36%, a 45% increase from 2023.
  • Monte Rosa Therapeutics, Inc. annual Return On Equity for 2023 was -66%, a 81% decline from 2022.
  • Monte Rosa Therapeutics, Inc. annual Return On Equity for 2022 was -36%, a 25% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Monte Rosa Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 8.3% +71% 01 Jul 2025 30 Sep 2025
Q2 2025 10% +80% 01 Apr 2025 30 Jun 2025
Q1 2025 2.6% +77% 01 Jan 2025 31 Mar 2025
Q4 2024 -36% +30% +45% 01 Oct 2024 31 Dec 2024
Q3 2024 -63% -4.5% -7.7% 01 Jul 2024 30 Sep 2024
Q2 2024 -70% -21% -43% 01 Apr 2024 30 Jun 2024
Q1 2024 -74% -32% -76% 01 Jan 2024 31 Mar 2024
Q4 2023 -66% -29% -81% 01 Oct 2023 31 Dec 2023
Q3 2023 -58% -26% -82% 01 Jul 2023 30 Sep 2023
Q2 2023 -49% -21% -76% 01 Apr 2023 30 Jun 2023
Q1 2023 -42% -18% -72% 01 Jan 2023 31 Mar 2023
Q4 2022 -36% -7.2% -25% 01 Oct 2022 31 Dec 2022
Q3 2022 -32% +14% +30% 01 Jul 2022 30 Sep 2022
Q2 2022 -28% +76% +73% 01 Apr 2022 30 Jun 2022
Q1 2022 -24% -135% -122% 01 Jan 2022 31 Mar 2022
Q4 2021 -29% -154% -123% 01 Oct 2021 31 Dec 2021
Q3 2021 -46% 01 Jul 2021 30 Sep 2021
Q2 2021 -104% 01 Apr 2021 30 Jun 2021
Q1 2021 110% 01 Jan 2021 31 Mar 2021
Q4 2020 125% 01 Oct 2020 31 Dec 2020

Monte Rosa Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -36% +30% +45% 01 Jan 2024 31 Dec 2024
2023 -66% -29% -81% 01 Jan 2023 31 Dec 2023
2022 -36% -7.2% -25% 01 Jan 2022 31 Dec 2022
2021 -29% -154% -123% 01 Jan 2021 31 Dec 2021
2020 125% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.